 However, in this case the parent compound does not have the side effects associated with terfenadine, and so both loratadine and its active metabolite, desloratadine, are currently marketed.Approximately 10% of all marketed drugs worldwide can be considered prodrugs.Since 2008, at least 30 prodrugs have been approved by the FDA.